Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001
聚乙二醇化透明质酸酶α (PEGPH20) 联合帕博利珠单抗治疗透明质酸高表达、既往接受过治疗的转移性胰腺导管腺癌患者的 II 期研究:PCRT16-001
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18030507
Chiorean, Elena Gabriela; Damle, Sheela R; Zhen, David B; Whittle, Martin; George, Ben; Hochster, Howard; Coveler, Andrew L; Hendifar, Andrew; Dragovich, Tomislav; Safyan, Rachael A; King, Gentry T; Harris, William P; Dion, Barbara; Stoll D'Astice, Amy; Lee, Arthur; Thorsen, Shelley; Kugel, Sita; Rosenthal, Adam; Hingorani, Sunil